{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:b1879337-3bfd-4ab4-8159-762d72ab4598","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-15T21:13:20.105261+00:00","published_at":"2026-10-15T04:46:46.95181+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:1ely6ok1h72a1c","event_type":"DIRECTOR_APPOINTED","effective_at":"2022-01-01","detected_at":"2026-10-15T04:46:46.95181+00:00","subject_ids":["alpha:person:martin-s-brown-jr","alpha:company:b1879337-3bfd-4ab4-8159-762d72ab4598"],"caused_claim_ids":["alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:1bfd4de8468de9c939c2b2967a18041718a5968edb0e52afecffe2e58ae1aadc"],"summary":"Martin S. Brown, Jr. seat on CUMBERLAND PHARMACEUTICALS INC, effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1rsict81nxnfbs","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-15T04:46:46.95181+00:00","subject_ids":["alpha:person:joseph-c-galante","alpha:company:b1879337-3bfd-4ab4-8159-762d72ab4598"],"caused_claim_ids":["alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:1bfd4de8468de9c939c2b2967a18041718a5968edb0e52afecffe2e58ae1aadc"],"summary":"Joseph C. Galante seat on CUMBERLAND PHARMACEUTICALS INC, effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:15ola4eywi0fo","event_type":"COMMITTEE_CREATED","effective_at":"2018-01-01","detected_at":"2026-10-15T04:46:46.95181+00:00","subject_ids":["alpha:committee:cumberland-pharmaceuticals-inc:audit-chair","alpha:company:b1879337-3bfd-4ab4-8159-762d72ab4598"],"caused_claim_ids":["alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:1bfd4de8468de9c939c2b2967a18041718a5968edb0e52afecffe2e58ae1aadc"],"summary":"Audit · Chair committee of CUMBERLAND PHARMACEUTICALS INC, effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:kl7n4e18b2a4e","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2018-01-01","detected_at":"2026-10-15T04:46:46.95181+00:00","subject_ids":["alpha:person:joseph-c-galante","alpha:committee:cumberland-pharmaceuticals-inc:audit-chair"],"caused_claim_ids":["alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:1bfd4de8468de9c939c2b2967a18041718a5968edb0e52afecffe2e58ae1aadc"],"summary":"Joseph C. Galante member of Audit · Chair, effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:y33lktye3b97","event_type":"DIRECTOR_APPOINTED","effective_at":"2017-01-01","detected_at":"2026-10-15T04:46:46.95181+00:00","subject_ids":["alpha:person:kenneth-j-krogulski","alpha:company:b1879337-3bfd-4ab4-8159-762d72ab4598"],"caused_claim_ids":["alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:1bfd4de8468de9c939c2b2967a18041718a5968edb0e52afecffe2e58ae1aadc"],"summary":"Kenneth J. Krogulski seat on CUMBERLAND PHARMACEUTICALS INC, effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1xi066rp0fmfh","event_type":"DIRECTOR_APPOINTED","effective_at":"2016-01-01","detected_at":"2026-10-15T04:46:46.95181+00:00","subject_ids":["alpha:person:caroline-r-young","alpha:company:b1879337-3bfd-4ab4-8159-762d72ab4598"],"caused_claim_ids":["alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:1bfd4de8468de9c939c2b2967a18041718a5968edb0e52afecffe2e58ae1aadc"],"summary":"Caroline R. Young seat on CUMBERLAND PHARMACEUTICALS INC, effective 2016-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ly31w2ua8ut0","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2016-01-01","detected_at":"2026-10-15T04:46:46.95181+00:00","subject_ids":["alpha:person:caroline-r-young","alpha:committee:cumberland-pharmaceuticals-inc:compensation"],"caused_claim_ids":["alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:committee_record:16"],"evidence_ids":["alpha:projection-evidence:a27f02b8fd03147b524d801def20b71dc8d883cd06b8fa8ad7926d598f1f591b"],"summary":"Caroline R. Young member of Compensation, effective 2016-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:18k36m2uc31jq","event_type":"DIRECTOR_APPOINTED","effective_at":"2010-01-01","detected_at":"2026-10-15T04:46:46.95181+00:00","subject_ids":["alpha:person:gordon-r-bernard","alpha:company:b1879337-3bfd-4ab4-8159-762d72ab4598"],"caused_claim_ids":["alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:1bfd4de8468de9c939c2b2967a18041718a5968edb0e52afecffe2e58ae1aadc"],"summary":"Gordon R. Bernard seat on CUMBERLAND PHARMACEUTICALS INC, effective 2010-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:145vxpjobwud1","event_type":"DIRECTOR_APPOINTED","effective_at":"2010-01-01","detected_at":"2026-10-15T04:46:46.95181+00:00","subject_ids":["alpha:person:james-r-jones","alpha:company:b1879337-3bfd-4ab4-8159-762d72ab4598"],"caused_claim_ids":["alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:1bfd4de8468de9c939c2b2967a18041718a5968edb0e52afecffe2e58ae1aadc"],"summary":"James R. Jones seat on CUMBERLAND PHARMACEUTICALS INC, effective 2010-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:mwfpbxrc3syv","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2010-01-01","detected_at":"2026-10-15T04:46:46.95181+00:00","subject_ids":["alpha:person:james-r-jones","alpha:committee:cumberland-pharmaceuticals-inc:audit"],"caused_claim_ids":["alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:committee_record:12"],"evidence_ids":["alpha:projection-evidence:a27f02b8fd03147b524d801def20b71dc8d883cd06b8fa8ad7926d598f1f591b"],"summary":"James R. Jones member of Audit, effective 2010-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:120nl4415qkotm","event_type":"COMMITTEE_CREATED","effective_at":"2010-01-01","detected_at":"2026-10-15T04:46:46.95181+00:00","subject_ids":["alpha:committee:cumberland-pharmaceuticals-inc:compensation-chair","alpha:company:b1879337-3bfd-4ab4-8159-762d72ab4598"],"caused_claim_ids":["alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:1bfd4de8468de9c939c2b2967a18041718a5968edb0e52afecffe2e58ae1aadc"],"summary":"Compensation · Chair committee of CUMBERLAND PHARMACEUTICALS INC, effective 2010-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:trerqn1a378r1","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2010-01-01","detected_at":"2026-10-15T04:46:46.95181+00:00","subject_ids":["alpha:person:gordon-r-bernard","alpha:committee:cumberland-pharmaceuticals-inc:compensation-chair"],"caused_claim_ids":["alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:1bfd4de8468de9c939c2b2967a18041718a5968edb0e52afecffe2e58ae1aadc"],"summary":"Gordon R. Bernard member of Compensation · Chair, effective 2010-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:17c8wl51ak1mtv","event_type":"DIRECTOR_APPOINTED","effective_at":"1999-01-01","detected_at":"2026-10-15T04:46:46.95181+00:00","subject_ids":["alpha:person:a-j-kazimi","alpha:company:b1879337-3bfd-4ab4-8159-762d72ab4598"],"caused_claim_ids":["alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:1bfd4de8468de9c939c2b2967a18041718a5968edb0e52afecffe2e58ae1aadc"],"summary":"A.J. Kazimi seat on CUMBERLAND PHARMACEUTICALS INC, effective 1999-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:5","subject_id":"alpha:company:b1879337-3bfd-4ab4-8159-762d72ab4598","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:a-j-kazimi","object_label":"A.J. Kazimi","object_source_name_forms":[],"value":"A.J. Kazimi: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:a-j-kazimi","name":"A.J. Kazimi"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"1999-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"1999-01-01","valid_to":null,"recorded_at":"2026-10-15T04:46:46.95181+00:00","sources":[{"id":"alpha:projection-evidence:document:1bfd4de8468de9c939c2b2967a18041718a5968edb0e52afecffe2e58ae1aadc","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"CUMBERLAND PHARMACEUTICALS INC DEF 14A 2026-03-09","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000025/cpix-20260309.htm","source_date":"2026-03-09","retrieved_at":"2026-04-25T00:24:02.036+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-09","effective_from":"1999-01-01","effective_until":null,"observed_at":"2026-10-15T04:46:46.95181+00:00","reviewed_at":"2026-10-15T04:46:46.95181+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:6","subject_id":"alpha:company:b1879337-3bfd-4ab4-8159-762d72ab4598","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:caroline-r-young","object_label":"Caroline R. Young","object_source_name_forms":[],"value":"Caroline R. Young: Director, Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:caroline-r-young","name":"Caroline R. Young"},"title":"Director","role_category":"director","committee":"Compensation","is_board_chair":false,"is_independent":true,"start_date":"2016-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2016-01-01","valid_to":null,"recorded_at":"2026-10-15T04:46:46.95181+00:00","sources":[{"id":"alpha:projection-evidence:document:1bfd4de8468de9c939c2b2967a18041718a5968edb0e52afecffe2e58ae1aadc","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"CUMBERLAND PHARMACEUTICALS INC DEF 14A 2026-03-09","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000025/cpix-20260309.htm","source_date":"2026-03-09","retrieved_at":"2026-04-25T00:24:02.036+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-09","effective_from":"2016-01-01","effective_until":null,"observed_at":"2026-10-15T04:46:46.95181+00:00","reviewed_at":"2026-10-15T04:46:46.95181+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:7","subject_id":"alpha:company:b1879337-3bfd-4ab4-8159-762d72ab4598","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:gordon-r-bernard","object_label":"Gordon R. Bernard","object_source_name_forms":[],"value":"Gordon R. Bernard: Director, Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:gordon-r-bernard","name":"Gordon R. Bernard"},"title":"Director","role_category":"director","committee":"Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2010-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2010-01-01","valid_to":null,"recorded_at":"2026-10-15T04:46:46.95181+00:00","sources":[{"id":"alpha:projection-evidence:document:1bfd4de8468de9c939c2b2967a18041718a5968edb0e52afecffe2e58ae1aadc","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"CUMBERLAND PHARMACEUTICALS INC DEF 14A 2026-03-09","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000025/cpix-20260309.htm","source_date":"2026-03-09","retrieved_at":"2026-04-25T00:24:02.036+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-09","effective_from":"2010-01-01","effective_until":null,"observed_at":"2026-10-15T04:46:46.95181+00:00","reviewed_at":"2026-10-15T04:46:46.95181+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:8","subject_id":"alpha:company:b1879337-3bfd-4ab4-8159-762d72ab4598","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:james-r-jones","object_label":"James R. Jones","object_source_name_forms":[],"value":"James R. Jones: Director, Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:james-r-jones","name":"James R. Jones"},"title":"Director","role_category":"director","committee":"Audit","is_board_chair":false,"is_independent":true,"start_date":"2010-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2010-01-01","valid_to":null,"recorded_at":"2026-10-15T04:46:46.95181+00:00","sources":[{"id":"alpha:projection-evidence:document:1bfd4de8468de9c939c2b2967a18041718a5968edb0e52afecffe2e58ae1aadc","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"CUMBERLAND PHARMACEUTICALS INC DEF 14A 2026-03-09","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000025/cpix-20260309.htm","source_date":"2026-03-09","retrieved_at":"2026-04-25T00:24:02.036+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-09","effective_from":"2010-01-01","effective_until":null,"observed_at":"2026-10-15T04:46:46.95181+00:00","reviewed_at":"2026-10-15T04:46:46.95181+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:9","subject_id":"alpha:company:b1879337-3bfd-4ab4-8159-762d72ab4598","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:joseph-c-galante","object_label":"Joseph C. Galante","object_source_name_forms":[],"value":"Joseph C. Galante: Director, Audit · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:joseph-c-galante","name":"Joseph C. Galante"},"title":"Director","role_category":"director","committee":"Audit · Chair","is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-15T04:46:46.95181+00:00","sources":[{"id":"alpha:projection-evidence:document:1bfd4de8468de9c939c2b2967a18041718a5968edb0e52afecffe2e58ae1aadc","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"CUMBERLAND PHARMACEUTICALS INC DEF 14A 2026-03-09","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000025/cpix-20260309.htm","source_date":"2026-03-09","retrieved_at":"2026-04-25T00:24:02.036+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-09","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-15T04:46:46.95181+00:00","reviewed_at":"2026-10-15T04:46:46.95181+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:10","subject_id":"alpha:company:b1879337-3bfd-4ab4-8159-762d72ab4598","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:kenneth-j-krogulski","object_label":"Kenneth J. Krogulski","object_source_name_forms":[],"value":"Kenneth J. Krogulski: Director, Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:kenneth-j-krogulski","name":"Kenneth J. Krogulski"},"title":"Director","role_category":"director","committee":"Audit","is_board_chair":false,"is_independent":true,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-15T04:46:46.95181+00:00","sources":[{"id":"alpha:projection-evidence:document:1bfd4de8468de9c939c2b2967a18041718a5968edb0e52afecffe2e58ae1aadc","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"CUMBERLAND PHARMACEUTICALS INC DEF 14A 2026-03-09","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000025/cpix-20260309.htm","source_date":"2026-03-09","retrieved_at":"2026-04-25T00:24:02.036+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-09","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-15T04:46:46.95181+00:00","reviewed_at":"2026-10-15T04:46:46.95181+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:leadership_role:11","subject_id":"alpha:company:b1879337-3bfd-4ab4-8159-762d72ab4598","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:martin-s-brown-jr","object_label":"Martin S. Brown, Jr.","object_source_name_forms":[],"value":"Martin S. Brown, Jr.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:martin-s-brown-jr","name":"Martin S. Brown, Jr."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-15T04:46:46.95181+00:00","sources":[{"id":"alpha:projection-evidence:document:1bfd4de8468de9c939c2b2967a18041718a5968edb0e52afecffe2e58ae1aadc","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"CUMBERLAND PHARMACEUTICALS INC DEF 14A 2026-03-09","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000025/cpix-20260309.htm","source_date":"2026-03-09","retrieved_at":"2026-04-25T00:24:02.036+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-09","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-15T04:46:46.95181+00:00","reviewed_at":"2026-10-15T04:46:46.95181+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:committee_record:12","subject_id":"alpha:company:b1879337-3bfd-4ab4-8159-762d72ab4598","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair Joseph C. Galante; Members Joseph C. Galante (Chair); James R. Jones; Kenneth J. Krogulski","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"Joseph C. Galante","members":[{"display_name":"Joseph C. Galante","person_slug":"joseph-c-galante","is_chair":true},{"display_name":"James R. Jones","person_slug":"james-r-jones","is_chair":false},{"display_name":"Kenneth J. Krogulski","person_slug":"kenneth-j-krogulski","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-15T04:46:46.95181+00:00","sources":[{"id":"alpha:projection-evidence:a27f02b8fd03147b524d801def20b71dc8d883cd06b8fa8ad7926d598f1f591b","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000025/cpix-20260309.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-15T04:46:46.95181+00:00","reviewed_at":"2026-10-15T04:46:46.95181+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:b1879337-3bfd-4ab4-8159-762d72ab4598:committee_record:16","subject_id":"alpha:company:b1879337-3bfd-4ab4-8159-762d72ab4598","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair Gordon R. Bernard; Members Gordon R. Bernard (Chair); Caroline R. Young","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":"Gordon R. Bernard","members":[{"display_name":"Gordon R. Bernard","person_slug":"gordon-r-bernard","is_chair":true},{"display_name":"Caroline R. Young","person_slug":"caroline-r-young","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-15T04:46:46.95181+00:00","sources":[{"id":"alpha:projection-evidence:a27f02b8fd03147b524d801def20b71dc8d883cd06b8fa8ad7926d598f1f591b","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000025/cpix-20260309.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-15T04:46:46.95181+00:00","reviewed_at":"2026-10-15T04:46:46.95181+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:1bfd4de8468de9c939c2b2967a18041718a5968edb0e52afecffe2e58ae1aadc","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"CUMBERLAND PHARMACEUTICALS INC DEF 14A 2026-03-09","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000025/cpix-20260309.htm","source_date":"2026-03-09","retrieved_at":"2026-04-25T00:24:02.036+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:a27f02b8fd03147b524d801def20b71dc8d883cd06b8fa8ad7926d598f1f591b","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000025/cpix-20260309.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.833,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.856,"cross_source_agreement":0.75,"temporal_completeness":0.583},"diagnostics":{"published_claims":18,"factual_claims":18,"claims_with_linked_evidence":18,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":12,"temporal_claims_with_valid_from":7,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","executive_role","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-15T04:46:46.95181+00:00","observed_at":"2026-10-15T04:46:46.95181+00:00","reviewed_at":"2026-10-15T04:46:46.95181+00:00","verified_at":"2026-10-15T04:46:46.95181+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":18,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/cumberland-pharmaceuticals-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/cumberland-pharmaceuticals-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}